Union Hospital, Tongji Medical College, Huazhong University of Science and Technology: Lupus Erythematosus, Systemic trials
The registry lists 10 Lupus Erythematosus, Systemic studies with Union Hospital, Tongji Medical College, Huazhong University of Science and Technology as lead sponsor. 7 are open to participants now and 0 have results posted.
Early Phase 1 3Phase 1 4Phase 2 1No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Study of YKST02 Alone or in Combination With YK012 in Patients With Active or Refractory Systemic Lupus ErythematosusNot yet recruitingNCT07512947Phase 1
- Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune DiseasesRecruitingNCT07470151Not applicable
- A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Dynamics of Universal CD19 / 20 Car-t Cell Injection in Moderate to Severe Refractory Systemic Lupus ErythematosusRecruitingNCT07339332Early Phase 1
- Safety, Efficacy and Cellular Metabolic Dynamics of ct1192 in Patients With Moderate to Severe Refractory SLERecruitingNCT07031713Phase 1
- A Study of CAR-T Cells in Subjects With Systemic Lupus ErythematosusNot yet recruitingNCT06900764Not applicable
- Clinical Study of A-319 in the Treatment of Active/Refractory Systemic Lupus ErythematosusRecruitingNCT06400537Phase 1
- A Clinical Study of CD19 Universal CAR-γδT Cells in Active Systemic Lupus ErythematosusRecruitingNCT06106893Phase 1/2
- A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Autoimmune DiseasesWithdrawnNCT07583030Early Phase 1
- A Study of LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus ErythematosusCompletedNCT06653556Early Phase 1
- Anti-CD19 CAR-T Cell Therapy in Participants With Moderate to Severe Active Systemic Lupus ErythematosusSuspendedNCT06310811Not applicable